drugset / Trial / NCT03790800

Intensive Ambulance-delivered Blood Pressure Reduction in Hyper-Acute Stroke Trial

NCT03790800

RandomizedParallel-groupSingle-blindTreatment

Summary

A multicentre, ambulance-delivered, prospective, randomized, open-label, blinded endpoint (PROBE) study to assess the effects of hyperacute intensive blood pressure (BP) lowering initiated in ambulance setting on (i) functional outcome in patients with acute stroke (ii) safety in patients with confirmed acute stroke and other conditions that were initially suspected as acute stroke (i.e. stroke mimic).

Timeline

Start
2020-03-20
Primary completion
2023-11-23
Completion
2023-11-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Urapidil Small molecule 25 mg Intravenous

Indications